Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.31−0.03 (-8.29%)
Close on Nov 18, 2026Market cap $2.51MP/E –Yield –
Q/C Technologies price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Q/C Technologies's price to book ratio was 0.2× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 273.1×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −0.7 |
| 2025 | Dec 31, 2025 | 0.8× | +0.7 |
| 2024 | Dec 31, 2024 | 0.2× | −24.1 |
| 2023 | Dec 29, 2023 | 24.3× | −52.3 |
| 2022 | Dec 30, 2022 | 76.6× | −51.2 |
| 2021 | Dec 31, 2021 | 127.8× | +99.2 |
| 2020 | Jan 31, 2020 | 28.6× | −2.0 |
| 2019 | Dec 31, 2019 | 30.6× | −83.2 |
| 2018 | Dec 31, 2018 | 113.8× | +97.9 |
| 2017 | Dec 29, 2017 | 15.9× | −136.9 |
| 2016 | Dec 30, 2016 | 152.8× | +110.8 |
| 2015 | Dec 31, 2015 | 42.0× | −41.0 |
| 2014 | Dec 31, 2014 | 83.0× | – |
See a number that looks wrong?